Академический Документы
Профессиональный Документы
Культура Документы
injury
Pathogenesis and Treatment
dr. Lestariningsih SpPD KGH
Subbag Nefrologi/Hipertensi Bagian Penyakit Dalam
FK UNDIP/RS Dr. Kariadi Semarang
Definition
Subtypes
Aetiology
Pre-renal ARF
Intrinsic ARF
Post-renal ARF
Principles of investigation
Pre-renal ARF
Reversible fall in GFR due to renal
hypoperfusion
Hypovolaemia
Haemorrhage, burns, GI fluid loss, renal fluid loss
Hypotension
Cardiogenic shock, sepsis
Renal hypoperfusion
renal vasoconstriction, drugs, liver disease, renal vascular
disease
Renal ARF
Disease of the renal parenchyma
ATN
Ischaemia, direct toxicity, myoglobin, sepsis
Vascular disease
Vasculitis, atheroemboli, infarction
Diseases of glomeruli/arterioles
RPGN, myeloma, HUS, vasculitis, SLE
Tubulo-interstitial nephritis
Drug related, paraneoplastic
Post-renal ARF
Renal failure secondary to urinary tract
obstruction
Ureteric
Calculi, carcinoma, retroperitoneal fibrosis,
stricture
Bladder neck
prostatic hypertrophy/malignancy, carcinoma,
neuropathy, blocked catheter
Prevention
Identify at risk patients
pre-existing CRF, diabetes, jaundice, myeloma,
elderly
History
When did it start?
What was the baseline renal function?
Pre -existing medical conditions
Examination
Current volume status
Skin turgor, oedema, lung bases, heart
sounds, central pressures, blood pressure
Bladder and kidneys
Signs of systemic disease
rashes, anaemia,
Investigations
Laboratory
Investigation
Radiology
Plain abdomen, renal U/S, IVU, CT scanning, renal
angiography, isotope renography
Renal biopsy
Treatment
Correct renal perfusion
Optimise volume status
Inotropes
Remove nephrotoxins
Relieve obstruction
Bladder catheter
Nephrostomies
Treatment
Make the patient safe
Hyperkalaemia
Volume overload
Uraemia
Acidosis
Specific treatments
Antibiotics, steroids
Methods of treatment
DRUG
DOSE
DURATION
Calcium Gluconate
10 ml of 10%
30 minutes
Glucose + Insulin
50 ml 50% + 8U
1 - 4 hours
IV Na Bicarbonate
1l of 1.4%
1 - 8 hours
Ventolin Nebuliser
5 ml
1 - 4 hours
Resonium
30 - 60 g (po/pr)
days
Bendrofluazide
5mg
days
Dialysis
Acute intermittent haemodialysis
Continuous dialysis treatments
Peritoneal dialysis
Hemodialysis
Outcome
Full recovery
Partial recovery
No recovery - progress to ESRF
Death
Conclusion
ARF is a life-threatening condition
Many cases can be avoided
Early diagnosis and expert treatment is
associated with a better outcome
ARF requiring specific treatment, especially
urinary tract obstruction and RPGN must not
be missed
Urgent treatment is needed for life-threatening
complications